Denial of clinical data is unfortunate. It's the only "currency" of a biotech -- either they meet clinical trial end points or the company is dead. Any investor that doesn't understand that shouldn't be investing in biotechs.
Monroe1- it’s a concept they don’t want to grasp. CyDy ‘s EINDS we’re successful in large part because we used 4 doses in many cases. The FDA saw this and realized it would have to approve Leronlimab if in fact a 4 dose trial was given. As we all know it wasn’t. That number of 62 that everyone keeps referring to as a small subset was achieved with only 2 doses let’s not forget that with 4 doses that 82% would have jumped even higher and across the board. If this drug didn’t work do you really think it would be the subject of this much attention. Longs keep fighting as I know you will this thing is certainly not over
Monroe , " When leronlimab is used , it works . pretty hard concept to grasp."
Yes, when leronlimab is use , its work..but FDA decided to sabotage CD12 , company applied according to Dr Lalezari for 4 weeks treatment for severe and critical patients , but FDA refused to approve it , and cut treatment to 2 weeks.
Why was that ,??
Drug is use for many years already weekly in patients, without stopping , and without one serious side effects.. why will anyone limit to 2 doses patients dying on the ventilators and ECMO..
It was very difficult to find explanation , but now we know .. Vaccination must receive EUA and be mandated , and for that no good drug could be approve...
So not one good drug is approved for hospitalized patients , and about 1 million American died by now, in CD12 , critical patients , at 14 days when leronlimab was still in the system , mortality benefit above all the toxic SOC drugs was 82% ..
82% mortality benefit ABOVE all the SOC drugs ..
Was FDA excited about it , no... They needed to fine something not to give EUA ... So it was ....ONLY 62 patients...only subgroup etc...
ONLY 62 ???
We all know , the less patients in the group the more difficult to prove efficacy.. They were not even curious how to help this company with great drug to save lives... no interest at all.
Below again Veritas video with FDA executive , how and why they need to mandate vaccines..
" it bring recurrent revenue in billions to the company every year " and " hundreds of millions company is giving to the FDA.."
" vaccine must be mandate.."
Even for 6 months old and up , dont we see side effects and a very little efficacy in young ?
" yes, and we dont know what will happen long time after the vaccine " .." but it is covid , so it will be mandate "
I listen to this video , every few days , and each time I have a hard time to believe it...
News 
Market Data 
Discover 
